Inhibition of C/EBPβ activity reduced AEP‐mediated cleavage of APP and Tau hyperphosphorylation, further underscoring the neuroprotective effects of BYHWD in the AD model and offering novel mechanistic insights for AD intervention. Here, APP is linked to Alzheimer disease.